Cytosorbents Corporation (FRA:HQE1)
Germany flag Germany · Delayed Price · Currency is EUR
0.5320
-0.0160 (-2.92%)
At close: Jan 22, 2026

Cytosorbents Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-10.27-20.72-29.25-32.81-24.56-7.84
Depreciation & Amortization
1.671.742.021.131.130.66
Other Amortization
0.760.38---0.32
Loss (Gain) From Sale of Assets
---0.13--
Asset Writedown & Restructuring Costs
0.20.330.660.64--
Stock-Based Compensation
2.83.764.163.86.24.71
Provision & Write-off of Bad Debts
0.030.120.01-0.01-0-0.1
Other Operating Activities
-3.974.34-1.912.452.58-2.61
Change in Accounts Receivable
-0.53-1.72-0.25-1.290.42-0.33
Change in Inventory
-0.90.50.180.95-2.35-0.46
Change in Accounts Payable
1.19-1.811.61-3.252.431.11
Change in Other Net Operating Assets
-0.87-1.351.10.030.15-1.08
Operating Cash Flow
-9.89-14.43-21.66-28.23-14.01-5.61
Capital Expenditures
-0.13-0.28-0.54-6.09-3.64-0.71
Sale (Purchase) of Intangibles
-0.12-0.39-0.4-0.37-0.64-0.97
Investing Cash Flow
-0.25-0.67-0.94-6.46-4.28-1.68
Long-Term Debt Issued
-15-5-1.41
Long-Term Debt Repaid
--5----16.41
Net Debt Issued (Repaid)
-10-5--15
Issuance of Common Stock
70.1814.47-0.8181.72
Other Financing Activities
0-0.85--0.04-0.09-0.38
Financing Cash Flow
79.3314.474.960.7266.35
Foreign Exchange Rate Adjustments
0.03-0.08-0.1-0.26-0.020.13
Net Cash Flow
-3.11-5.85-8.22-29.99-17.659.19
Free Cash Flow
-10.02-14.71-22.19-34.32-17.65-6.32
Free Cash Flow Margin
-27.09%-41.33%-71.39%-98.94%-40.88%-15.42%
Free Cash Flow Per Share
-0.17-0.27-0.50-0.79-0.41-0.16
Cash Interest Paid
2.051.290.38--1.13
Levered Free Cash Flow
-6.74-15-12.92-23.8-8.88-3.72
Unlevered Free Cash Flow
-5.94-14.5-12.82-23.8-8.88-3.29
Change in Working Capital
-1.11-4.382.65-3.560.64-0.76
Source: S&P Global Market Intelligence. Standard template. Financial Sources.